SB3075 Summary

• Establishes a pilot program allowing the board of psychology to grant prescriptive authority to qualified clinical psychologists licensed in Hawaii before January 1, 2020, and practicing in counties with populations under 100,000 persons.

• Requires prescribing psychologists to complete a post-doctoral master's degree in clinical psychopharmacology, pass the Psychopharmacology Examination for Psychologists, and complete at least 800 hours of supervised clinical experience including work with geriatric, pediatric, and pregnant patients.

• Mandates prescribing psychologists practice in consultation and collaboration with a primary care provider through written collaborative agreements before prescribing psychotropic medications, except for forensically encumbered patients and those with serious mental illness under the department of health's jurisdiction.

• Restricts prescribing psychologists from prescribing Schedule I, II, or III controlled substances, opiates, and narcotic drugs, but permits prescribing stimulants for attention deficit hyperactivity disorder regardless of schedule classification.

• Creates a sunset provision requiring the act to repeal on August 31, 2025, with the board of psychology to submit findings and recommendations to the legislature by January 2022.